Harlequin Ichthyosis: Severe Genetic Skin Disorder in Newborns

Harlequin ichthyosis (HI) is an autosomal recessive disorder caused by biallelic mutations in ABCA12 (ATP-binding cassette transporter for lipid transport in lamellar granules). Incidence ~1/300,000.

Clinical Features at Birth

  • Thick, armor-like, diamond-shaped hyperkeratotic plates with deep erythematous fissures.
  • Ectropion (everted eyelids), eclabium (everted lips), flattened ears/nose.
  • Restricted chest wall movement → respiratory compromise.
  • Impaired thermoregulation, dehydration, electrolyte imbalance, sepsis risk.

Management (NICU)

  • Humidified incubator (80–90% humidity), fluid/electrolyte monitoring.
  • Emollients (petrolatum, urea, lactic acid) q2–4h; gentle debridement.
  • Systemic retinoids (oral isotretinoin/acitretin) — accelerate shedding, improve survival.
  • Infection prophylaxis/ treatment.
  • Nutritional support (high calorie).
  • Ophthalmology for ectropion (lubrication, surgery later).

Prognosis

Historically fatal in neonatal period. With modern NICU care + retinoids, survival >90% into childhood. Lifelong ichthyosis (less severe), requiring daily emollients/retinoids. Multidisciplinary care essential.

Genetic Disorders - Related Articles